[HTML][HTML] COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
[HTML][HTML] Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in …
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases
R Felten, M Dubois, MF Ugarte-Gil… - The Lancet …, 2021 - thelancet.com
Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …
[HTML][HTML] COVID-19 vaccination in immunocompromised patients
Almost 1 year into the coronavirus disease 2019 (COVID-19) pandemic, and after more than
50 million cases and 1.35 million deaths globally, reports of the successful conclusion of …
50 million cases and 1.35 million deaths globally, reports of the successful conclusion of …
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
RH Haberman, S Um, JE Axelrad, RB Blank… - The Lancet …, 2022 - thelancet.com
Studies have revealed that patients with immunemediated inflammatory diseases, especially
those on immunomodulatory medication, have attenuated immunogenicity to COVID-19 …
those on immunomodulatory medication, have attenuated immunogenicity to COVID-19 …
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
L Wieske, KPJ van Dam, M Steenhuis… - The Lancet …, 2022 - thelancet.com
Background Disease-specific studies have reported impaired humoral responses after
SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated …
SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated …
Flare of rheumatoid arthritis after COVID-19 vaccination
KA Terracina, FK Tan - The Lancet Rheumatology, 2021 - thelancet.com
With the COVID-19 pandemic, there has been great uncertainty about whether the virus
could exacerbate autoimmune diseases such as rheumatoid arthritis given that infection can …
could exacerbate autoimmune diseases such as rheumatoid arthritis given that infection can …
[HTML][HTML] Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Background Real-world evidence on the association between autoimmune inflammatory
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are …
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
M Krasselt, U Wagner, P Nguyen, C Pietsch… - …, 2022 - academic.oup.com
Objectives Successful vaccination is key to overcoming the COVID-19 pandemic.
Immunosuppressive medication is known to potentially compromise vaccination responses …
Immunosuppressive medication is known to potentially compromise vaccination responses …
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
Comment www. thelancet. com/rheumatology Vol 4 February 2022 e81 p= 0· 039). The
neutralisation assay showed a moderate correlation (Pearson R 0· 35; p< 0· 001) with …
neutralisation assay showed a moderate correlation (Pearson R 0· 35; p< 0· 001) with …
相关搜索
- disease and treatment covid 19
- disease and treatment vaccine responses
- vaccine responses covid 19
- immune modulation covid 19
- sars cov humoral responses
- sars cov inflammatory disorders
- humoral responses inflammatory disorders
- option for treatment immune modulation
- concerns of patients covid 19
- inflammatory diseases opensafely platform
- inflammatory diseases covid 19
- inflammatory diseases vaccine responses
- effect of disease covid 19
- effect of disease vaccine responses
- option for treatment covid 19
- immunocompromised patients covid 19